Postoperative Ileus

• FDA approval · 2025-09-23
  FDA Approved: ALVIMOPAN — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for ALVIMOPAN submitted by Par Health USA, LLC.

• FDA approval · 2023-11-02
  FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Eugia US LLC)

  FDA approved the original application (ANDA 213244) for Neostigmine methylsulfate by Eugia US LLC, authorizing its generic entry and labelin…

• FDA approval · 2023-08-31
  FDA Approved: ALVIMOPAN — Original Application (Golden State Medical Supply, Inc.)

  FDA approved the original ANDA for ALVIMOPAN (alvimopan) from Golden State Medical Supply, Inc., granting generic status and market access.

• FDA approval · 2023-06-12
  FDA Approved: ALVIMOPAN — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for ALVIMOPAN (Actavis Pharma, Inc.), representing an additional regulatory approval step for this d…

• FDA approval · 2023-01-24
  FDA Approved: ALVIMOPAN — Original Application (Par Health USA, LLC)

  The FDA approved Par Health USA, LLC's original ANDA for ALVIMOPAN, granting a generic version of alvimopan. The approval makes ALVIMOPAN av…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2022-11-16
  FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approved a supplemental ANDA for Neostigmine methylsulfate by Amneal Pharmaceuticals LLC.

• FDA approval · 2021-10-01
  FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Indoco Remedies Limited)

  FDA approved the original application for NEOSTIGMINE METHYLSULFATE from Indoco Remedies Limited (ANDA210652). The approval supports its use…

• FDA approval · 2019-12-19
  FDA Approved: ALVIMOPAN — Original Application (Actavis Pharma, Inc.)

  The FDA approved ALVIMOPAN (alvimopan) from Actavis Pharma, Inc. via an original ANDA, granting marketing authorization for this generic pro…

• FDA approval · 2017-09-25
  FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Amphastar Pharmaceuticals, Inc.)

  FDA approved Amphastar Pharmaceuticals' neostigmine methylsulfate as an original ANDA (ANDA209933) for indications including treatment of my…

• FDA approval · 2015-12-28
  FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Civica, Inc.)

  FDA approved Civica, Inc.'s original application for Neostigmine Methylsulfate, a generic version of the drug.

• FDA approval · 2010-05-04
  FDA Approved: BETHANECHOL CHLORIDE — Original Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.)

  FDA approved Bethanechol chloride under an original generic application from Heritage Pharma Labs (Avet Pharmaceuticals Labs Inc.).

• FDA approval · 2007-11-21
  FDA Approved: BETHANECHOL CHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved Amneal Pharmaceuticals of New York LLC's Bethanechol chloride as an original generic application (ANDA). It is indicated for no…

• FDA approval · 2007-10-26
  FDA Approved: BETHANECHOL CHLORIDE — Original Application (Chartwell RX, LLC)

  FDA approved Bethanechol chloride under an Original Application from Chartwell RX, LLC.